Tel: 01789 267520

Latest News: Research

Reproductive Choices in Families with SMA – A Survey

23 February 2016 / Posted in: Research

Families are invited to participate in a US based research survey looking at reproductive choices in families with SMA, specifically in regards to choices surrounding preimplantation genetic diagnosis. The closing date for completing the survey is 15th May.

Read full story

Eurordis (European Organisation for Rare Diseases) Needs Your Expertise

16 February 2016 / Posted in: Research

Eurordis is conducting a survey in an effort to better understand how well people are engaged in decisions about their medical care.

Read full story

Biogen and Ionis Pharmaceuticals Provide Update on Nusinersen (Formerly Known as ISIS-SMNRx)

31 January 2016 / Posted in: Research

Biogen and Ionis Pharmaceuticals (previously Isis Pharmaceuticals) have provided an update on the clinical development of their antisense oligonucleotide drug Nusinersen, which used to be known as Isis-SMNRx.

Read full story

Two New Clinical Care Research Articles

12 January 2016 / Posted in: Research

Dr. Alex Murphy, our Clinical Care Research Correspondent, has written two review articles; one about diet and SMA and one about exercise and SMA.

Read full story

Cytokinetics Initiates Phase II Trial of Potential SMA Drug

11 January 2016 / Posted in: Research

Cytokinetics and Astellas have begun enrolling SMA patients in a Phase II clinical trial of their muscle-activating drug, CK-2127107.

Read full story

Roche Provides Updates on New Compound and Moonfish Trial

11 January 2016 / Posted in: Research

Roche, PTC Therapeutics, and the SMA Foundation have announced that they are to begin testing a second splice-modifying drug with potential to treat SMA.

Read full story

Avexis Completes Phase I Trial Patient Enrolment

08 January 2016 / Posted in: Research

Avexis has announced that patient enrolment is complete in a Phase I clinical trial of their gene therapy drug, scAAV9.CB.SMN.

Read full story

Isis Pharmaceuticals changes its name to Ionis Pharmaceuticals

06 January 2016 / Posted in: Research

After almost a year of deliberation, Isis Pharmaceuticals has rebranded itself as Ionis Pharmaceuticals in order to avoid confusion and negativity associated with Islamic State, also commonly known as Isis.

Read full story

Blood Vessel Defects Contribute to SMA Motor Neuron Loss

17 December 2015 / Posted in: Research

New research from the laboratory of Simon Parson (University of Aberdeen) and collaborators in London and Oxford indicates that a faulty blood supply may play an important role in the death of motor neurons seen in spinal muscular atrophy.

Read full story

A New Scientist Q & A

16 November 2015 / Posted in: Research

Read the latest scientist Q & A. Being interviewed this time is Ewout Groen. Ewout was recently awarded a prestigious Wellcome Trust Fellowship for early career researchers.

Read full story